Paper23929628
Advances and challenges in treatment and prevention of ischemic stroke.
Grossman AW and 1 other. Ann Neurol, 2013. Cited by 50 papers, by iCite.
Cite this record
ConductScience Library. Advances and challenges in treatment and prevention of ischemic stroke. Papers, record 23929628. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23929628
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Ischemia | Major topic |
| Fibrinolytic Agents | Major topic |
| Stroke | Major topic |
| Tissue Plasminogen Activator | Major topic |
| Humans | |
| Randomized Controlled Trials as Topic | |
| Research Design | |
| Thrombolytic Therapy |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P50 NS44283 | NINDS NIH HHS | United States | P50NS044283 | PubMed and NIH | NIH RePORTER |
| U01 NS052220 | NINDS NIH HHS | United States | U01NS052220 | PubMed and NIH | NIH RePORTER |
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38069179 | Endogenous Extracellular Vesicles Participate in Brain Remodeling after Ischemic Stroke. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38069179 | PubMed |
| 38041714 | Recent Advances and Therapeutic Implications of 2-Oxoglutarate-Dependent Dioxygenases in Ischemic Stroke. | Mol Neurobiol | 2024 | https://conductscience.org/library/papers/38041714 | PubMed |
| 37569591 | Pilot Study of Cytoprotective Mechanisms of Selenium Nanorods (SeNrs) under Ischemia-like Conditions on Cortical Astrocytes. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37569591 | PubMed |
| 37111522 | Stimuli-Responsive Nanotherapeutics for Treatment and Diagnosis of Stroke. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37111522 | PubMed |
| 36691091 | Synergistic therapeutic effects of intracerebral transplantation of human modified bone marrow-derived stromal cells (SB623) and voluntary exercise with running wheel in a rat model of ischemic stroke. | Stem Cell Res Ther | 2023 | https://conductscience.org/library/papers/36691091 | PubMed |
| 34789285 | A stepwise-targeting strategy for the treatment of cerebral ischemic stroke. | J Nanobiotechnology | 2021 | https://conductscience.org/library/papers/34789285 | PubMed |
| 34196879 | Modulation of α7nAchR by Melatonin Alleviates Ischemia and Reperfusion-Compromised Integrity of Blood-Brain Barrier Through Inhibiting HMGB1-Mediated Microglia Activation and CRTC1-Mediated Neuronal Loss. | Cell Mol Neurobiol | 2022 | https://conductscience.org/library/papers/34196879 | PubMed |
| 32321995 | Modelling human CNS injury with human neural stem cells in 2- and 3-Dimensional cultures. | Sci Rep | 2020 | https://conductscience.org/library/papers/32321995 | PubMed |
| 31920923 | A Network-Based Method for Mechanistic Investigation and Neuroprotective Effect on Post-treatment of Senkyunolid-H Against Cerebral Ischemic Stroke in Mouse. | Front Neurol | 2019 | https://conductscience.org/library/papers/31920923 | PubMed |
| 31552900 | Neuroprotective mechanism of TMP269, a selective class IIA histone deacetylase inhibitor, after cerebral ischemia/reperfusion injury. | Neural Regen Res | 2020 | https://conductscience.org/library/papers/31552900 | PubMed |
| 31083342 | The Role of Mast Cells in Stroke. | Cells | 2019 | https://conductscience.org/library/papers/31083342 | PubMed |
| 31008275 | Age disparity in diagnostic evaluation of stroke patients: Embolic Stroke of Undetermined Source Global Registry Project. | Eur Stroke J | 2016 | https://conductscience.org/library/papers/31008275 | PubMed |
| 30972000 | Combined Adipose Tissue-Derived Mesenchymal Stem Cell Therapy and Rehabilitation in Experimental Stroke. | Front Neurol | 2019 | https://conductscience.org/library/papers/30972000 | PubMed |
| 30008694 | Importance of Angiogenin and Endothelial Progenitor Cells After Rehabilitation Both in Ischemic Stroke Patients and in a Mouse Model of Cerebral Ischemia. | Front Neurol | 2018 | https://conductscience.org/library/papers/30008694 | PubMed |
| 29512704 | Intravenous administration of DPSCs and BDNF improves neurological performance in rats with focal cerebral ischemia. | Int J Mol Med | 2018 | https://conductscience.org/library/papers/29512704 | PubMed |
| 29348796 | Condition-specific transcriptional regulation of neuronal ion channel genes in brain ischemia. | Int J Physiol Pathophysiol Pharmacol | 2017 | https://conductscience.org/library/papers/29348796 | PubMed |
| 29316653 | Synergistic Association of Valproate and Resveratrol Reduces Brain Injury in Ischemic Stroke. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29316653 | PubMed |
| 29254225 | Transplantation of bFGF-expressing neural stem cells promotes cell migration and functional recovery in rat brain after transient ischemic stroke. | Oncotarget | 2017 | https://conductscience.org/library/papers/29254225 | PubMed |
| 27901117 | Sex-specific Association Between Uric Acid and Outcomes After Acute Ischemic Stroke: A Prospective Study from CATIS Trial. | Sci Rep | 2016 | https://conductscience.org/library/papers/27901117 | PubMed |
| 27879449 | Ethnic Comparison of Clinical Characteristics and Ischemic Stroke Subtypes Among Young Adult Patients With Stroke in Hawaii. | Stroke | 2017 | https://conductscience.org/library/papers/27879449 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23929628
GET https://conductscience.org/api/papers/v1/23929628/cited_by?page=2